Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings
- 66 Downloads
- 24 Citations
Summary
Clinical, neurochemical and neuropathological findings on a case of late-infantile Gaucher disease with oculomotor apraxia, progressive myoclonus and prominent bulbar signs are reported. There was a marked increase in glucosylceramide in cerebral cortex and cerebellum; the increase was more in the range of that seen in the Norrbottnian type III than in type II Gaucher disease. Cerebral cortical changes were characterized by a band-like intraparenchymal accumulation of Gaucher cells in lamina IV with an accompanying astrogliosis. In the cerebellum, a focal severe loss of granule cells and a global loss of dentate nucleus neurons was recorded. Milder changes were seen in thalamus and brain stem where perivascular accumulation of Gaucher cells was present in all regions. The cerebral cortical changes resembled those seen in type II Gaucher disease and was much more marked than in the Norrbottnian type III, whereas the changes in the dentate nucleus were more severe than in both type II and type III. The phenotypic variability with different patterns of clinical symptoms and neuropathological changes in neuronopathic Gaucher disease is discussed.
Key words
Gaucher disease Myoclonus Epilepsy Gaze palsy Bulbar signsPreview
Unable to display preview. Download preview PDF.
References
- 1.Conradi NG, Sourander P, Nilsson O, Svennerholm L, Eriksson A (1984) Neuropathology of the Norrbottnian type of Gaucher disease. Acta Neuropathol (Berl) 65:99–104Google Scholar
- 2.Dreborg S, Eriksson A, Hagberg B (1980) Gaucher disease —Norrbottnian type. I. General clinical description. Eur J Pediatr 133:107–118Google Scholar
- 3.Eriksson A (1986) Gaucher disease — Norrbottnian type (III). Neuropediatric and neurobiological aspects of clinical patterns and treatment. Acta Paediatr Scand [Suppl] 326:1–41Google Scholar
- 4.Fabbro D, Desnick RJ, Grabowski GA (1987) Gaucher disease: genetic hetogeneity within and among the subtypes detected by immunoblotting. Am J Hum Genet 40:15–31Google Scholar
- 5.Grover WD, Tucker SH, Wenger DA (1978) Clinical variation in two related children with neuronopathic Gaucher disease. Ann Neurol 3:281–283Google Scholar
- 6.Haltia M, Kristensson K, Sourander P (1968) Neuropathological studies in three Scandinavian cases of progressive myoclonus epilepsy. Acta Neurol Scand 45:63–77Google Scholar
- 7.Herrlin KM, Hillborg PO (1962) Neurological signs in a juvenile form of Gaucher's disease. Acta Paediatr Scand 51:137–154Google Scholar
- 8.Hillborg PO, Svennerholm L (1960) Blood levels of cerebrosides in Gaucher's disease. Acta Paediatr Scand 49:707–710Google Scholar
- 9.Kaye EM, Ullman MD, Wilson ER, Barranger JA (1986) Type 2 and type 3 Gaucher's disease: a morphological and biochemical study. Ann Neurol 20:223–230Google Scholar
- 10.King JO (1975) Progressive myoclonus epilepsy due to Gaucher's disease in an adult. J Neurol Neurosurg Psychiatry 38:849–854Google Scholar
- 11.Kyllerman M, Conradi N, Månsson J-E, Percy AK, Svennerholm L (1990) Partial splenectomy in a child with Gaucher type III disease. Acta Paediatr Scand 79:448–453Google Scholar
- 12.Miller JD, McCluer R, Kanfer JW (1973) Gaucher's disease. neurological disorder in adult siblings. Ann Intern Med 78:883–887Google Scholar
- 13.Nilsson O, Svennerholm (1982) Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease. J Neurochem 39:709–718Google Scholar
- 14.Nilsson O, Håkansson G, Dreborg S, Groth CG, Svennerholm L (1982) Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III. Clin Genet 22:274–279Google Scholar
- 15.Nishimura RN, Barranger JA (1980) Neurologic complication of Gaucher's disease type III. Arch Neurol 37:92–93Google Scholar
- 16.Rapin I (1986) Myoclonus in neuronal storage and Lafora diseases. Adv Neurol 43:67–68Google Scholar
- 17.Seitelberger F (1964) Über die Gehirnbeteiligung bei der Gaucherschen Krankheit im Kindesalter. Arch Psychiatr. Z Neurol 206:419–440Google Scholar
- 18.Svennerholm L, Fredman P (1980) A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta 817:97–109Google Scholar
- 19.Svennerholm L, Vanier MT, Månsson J-E (1980) Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. J Lipid Res 21:53–64Google Scholar
- 20.Svennerholm L, Håkansson G, Månsson J-E, Nilsson O (1982) Chemical differentiation of the Gaucher subtypes. In: Desnick RJ, Gatt S, Grabowski GA (eds) Gaucher disease: a century of delineation and research. Alan R Liss, pp 231–252, New YorkGoogle Scholar
- 21.Svennerholm L, Månsson J-E, Rosengren B (1986) Cerebroside-β-glucosidase activity in Gaucher brain. Clin Genet 30:131–135Google Scholar
- 22.Svennerholm L, Fredman P, Jungbjer B, Månsson J-E, Boström K, Hagberg B, Norén L, Santavouri P (1987) Large alteration in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis. J Neurochem 49:1772–1783Google Scholar
- 23.Theophilus B, Latham T, Grabowski GA, Smith FI (1989) Gaucher disease: molecular heterogeneity and phenotypegenotype correlations. Am J Hum Genet 45:212–225Google Scholar
- 24.Tripp JH, Lake BD, Young E, Ngu J, Brett EM (1977) Juvenile Gaucher's disease with horizontal gaze palsy in three siblings. J Neurol Neurosurg Psychiatry 40:470–478Google Scholar
- 25.Tsuji S, Choudary PV, Martin BM, Stubblefield BK, Mayor JA, Barranger JA, Ginns EI (1987) A mutation in the human glucocerebroside gene in neuronopathic Gaucher's disease. N Engl J Med 316:570–575Google Scholar
- 26.Winkelman MD, Banker BQ, Victor M, Moser HW (1983) Non-infantile neuronopathic Gaucher's disease: a clinicopathologic study. Neurology 33:994–1008Google Scholar